When two documented batches of a research peptide are compared, the laboratory concentration plan should remain an in-vitro calculation record. It can describe mass, diluent volume, nominal concentration, assay matrix and controls. It must not become a dosing instruction, an administration schedule or a clinical protocol. Materials supplied through Research Sciences are research-use-only and are not for human or veterinary use. The comparison is about documentation, traceability and analytical records, not about translating a stock solution into a therapeutic routine.
Why a Laboratory Concentration Plan Is Not a Dosing Instruction
In an in-vitro workflow, concentration is a variable within an experimental design. A researcher may plan a stock preparation and a dilution series for cell-free or cell-based work, but those values are tied to the assay matrix, detection range, solvent tolerance and controls. The plan should state the documented material amount, diluent type and volume, mixing conditions, and the intended assay concentration range. It should also record the batch label reference and the CoA. None of this is a dose; it is a laboratory dilution calculation.
The distinction matters when comparing Batch A with Batch B. The two may carry different label references, CoA documents or ITR links. Research Sciences explains that restocked products may carry the same Internal Test Reference as earlier stock, and that an ITR links to associated sample testing reports; it does not confirm that separate deliveries came from the same production lot or had separate independent testing. A concentration plan should therefore compare documents rather than assume equivalence. Use batch-specific language: “nominal concentration prepared for assay”, “dilution series”, “matrix compatibility” and “control wells”. Avoid wording that implies administration. The shop’s materials are not medicines, medical devices, injectables, treatments or food supplements under UK law; they are strictly for controlled laboratory and analytical research.
A common risk is copying a concentration figure from one batch record into another without noting the source. Better practice is to attach the relevant CoA and label reference to each calculation. Where a laboratory uses a reconstitution calculator, it is described for laboratory research use only and must not be used for human or veterinary dosing. The output should be filed as an in-vitro preparation calculation, not as a dosing instruction. If a product page mentions purity or testing, treat that as the shop’s current published wording and reconfirm it against the live page and the batch CoA.
Comparing Two Documented Batches Without Turning Records into Protocols
A disciplined batch comparison starts with the label. Vial labels use a reference format combining SKU code and expiry date, for example BPC10-03/27, linking to the corresponding CoA. Record that reference exactly in the laboratory notebook. Then open the CoA for each batch and compare the documented fields available to the researcher: identity, purity and any contaminant screening described in the shop’s documentation. Do not invent pass/fail limits or assume that two CoAs are identical. Research Sciences describes batch-level analytical verification and CoAs for products, but researchers should verify the actual batch document that accompanies the material. If the homepage lists “CoAs Janoshik Analytical Reports”, that is the shop’s wording; check the CoA supplied with the specific batch.
Packaging can mislead if it is over-interpreted. Vial cap colours and other packaging may vary, and cap colour is not an indicator of identity, analytical quality or manufacturing origin. The ITR is a documentation link, not a guarantee of a shared production lot. A batch comparison should therefore separate observed packaging from documented identity and analytical records. Before planning dilutions, review the current catalogue entry for the material, such as the Buy peptides category page, then open the individual product page and its CoA. That sequence keeps the selection, the batch reference and the concentration calculation connected.
Catalogue examples include Tesamorelin 5mg, TB-500 5mg, Ipamorelin 5mg, CJC-1295 (No DAC) 5mg, GHK-Cu 50mg, BPC-157 10mg, MT-1 10mg, and 10ml Mixing Water / Bacteriostatic Water 10ml wording also appears on the site. These are research-use-only materials, not medicines or supplements. All peptides are described as containing trace amounts of mannitol, an excipient used in lyophilisation and storage. That detail belongs in the batch record because it reminds the researcher that the vial is a formulated research material. It does not justify a dosing interpretation. The shop does not supply blended peptides and recommends buying peptides individually and combining only within a controlled experimental design.
Documentation, Storage and Traceability in Batch-to-Batch Reviews
Storage and handling notes should sit beside the concentration plan but remain clearly separate from it. Research Sciences guidance says to allow vials to reach room temperature before opening, work in a clean environment, and remove only the amount required for the experiment. Lyophilised peptides should be stored at –20°C or below, sealed with desiccant, protected from moisture, heat and light. Avoid repeated freeze–thaw cycles. Reconstituted peptides are less stable and should be stored at 2–8°C for short-term laboratory use. For an in-vitro study, the plan should record diluent volume, the final nominal concentration prepared for the assay, and the time of preparation. It should not record a dose, an administration route, or a schedule for a person or animal.
A batch-to-batch review is strongest when written as a traceability note. Include the product name, SKU and expiry label reference; the CoA document used; the ITR if mentioned; the storage history in the laboratory; the diluent and volume; the assay matrix; and the date in month-and-year format where a date is needed. Note any difference between the two batches without assuming that the difference changes analytical quality. If a figure from the shop’s current published wording is used, such as a purity statement or delivery estimate, attribute it to the live site and reconfirm it, including on the batch CoA where relevant. Delivery claims are estimates, not guarantees, and should not influence the scientific comparison.
For UK laboratory teams, good documentation also supports COSHH and local safety compliance. The purchaser is responsible for lawful use, safe handling, storage and disposal, and for checking suitability for the intended research application. Research Sciences states that products are labelled “For Research Use Only – Not for Human Consumption” and describes this as its position in line with MHRA guidance; this is not legal advice. Keep the language of the notebook rigidly in-vitro: stock preparation, assay dilution, matrix compatibility and analytical verification. That discipline prevents a concentration plan from drifting into a dosing instruction when two documented batches are placed side by side. The materials are not for human or veterinary use, and the comparison should remain a laboratory exercise in documentation, dilution and traceability.
Lyon pastry chemist living among the Maasai in Arusha. Amélie unpacks sourdough microbiomes, savanna conservation drones, and digital-nomad tax hacks. She bakes croissants in solar ovens and teaches French via pastry metaphors.